Learn More
Invitrogen™ IL-29 Monoclonal Antibody (247801)

Mouse Monoclonal Antibody
£389.00 - £576.00
Specifications
| Antigen | IL-29 |
|---|---|
| Clone | 247801 |
| Concentration | 0.5 mg/mL |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
| Applications | ELISA, Neutralization |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
15543482
|
Invitrogen™
MA523791 |
500 μg |
£576.00
500µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
15563592
![]() |
Invitrogen™
MA523903 |
100 μg |
£389.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
In sandwich ELISAs, 100% cross-reactivity with recombinant human (rh) IL-28B/IFN-lambda 3 and 20% with rhIL-28A is observed. No cross-reactivity or interference was observed with rhIFN-alpha A, rhIFN-alpha B2, rhIFN-alpha G, rhIFN-alpha I, or rhIFN- beta 1A. Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
IFN-lambdas constitute a novel family of interferons that mediate the induction of anti-viral protection in a wide variety of cells. There are three members in this family, namely lambda1, lambda2, and lambda3, which are also known as IL-29, IL-28A, and IL-28B, respectively. Similar to type I IFNs, IFN-lambdas activate an intracellular signaling to promote gene expression. IFN-lambdas mediate their anti-viral protection through a class II cytokine receptor complex composed of two essential receptor proteins, CRF2-12/IFN-lambdaR1, which is unique to IFN-lambdas, and CFR2-4/IL-10R2, which is shared with IL-10, IL-22, and IL-26 receptors. The IFN-lambdas, IL-28 and IL-29, have recently been reported to prime dendritic cells to induce proliferation of Foxp3-bearing regulatory T cells. DCs that differentiate in response to IFN-lambdas express high levels of class I and II MHC gene products, but low levels of costimulatory molecules. Moreover, these cells can specifically induce IL-2-dependent proliferation of CD4+CD25+FOXP3+ T cells with contact-dependent suppressive activity.Specifications
| IL-29 | |
| 0.5 mg/mL | |
| ELISA, Neutralization | |
| Unconjugated | |
| Mouse | |
| RUO | |
| PBS with 5% trehalose and No Preservative | |
| Q8IU54 | |
| 282618 | |
| Mouse myeloma cell line NS0-derived recombinant human IL-29/IFN-lambda 1 Gly20-Thr200. | |
| Antibody |
| 247801 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Monoclonal | |
| Lyophilized | |
| IgG2a | |
| Human | |
| IFNL1 | |
| cytokine Zcyto21; Cytokine Zcyto22; FNL1; IFN lambda1; IFNL1; IFNL3; IFN-lambda-1; IFN-lambda-3; IFN-lambda-4; IL28B; IL-28B; IL28C; IL-28C; IL29; IL-29; ILN; interferon lambda 1; interferon lambda 3; Interferon lambda1; interferon lambda-1; Interferon lambda-3; interferon, lambda 1; interferon, lambda 3; interferon, lambda 4; interferon-lambda-1; Interleukin; interleukin 29 (interferon, lambda 1); interleukin-28B; Interleukin-28C; interleukin-29; ZCYTO21; ZCYTO22 | |
| IFNL1 | |
| Primary | |
| Protein A/G |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.